Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109010) titled 'Skin Safety test of BTM Multiple Skin Care Products' on April 21.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: BTM Ventures Pvt

Intervention: Intervention1: Finn chamber: Each patch contains 0.04ml (40 microgram) of 1.Vitamin C face Serum 2.Niacinmide Face Serum 3.Vitamin C facewash 4.Niacinamide Face wash, Route of Administration: Topical Frequency: Once Duration:24hrs Control Intervention1: Finn chamber: 5.Negative control(0.9% NaCl), ...